MFG
GSK icon

MidWestOne Financial Group’s GSK GSK Stock Holding History

MidWestOne Financial Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,160
Closed -$227K – 230
2022
Q1 		$227K Hold
4,160
– – 0.05% 229
2021
Q4 		$229K Buy
+4,160
New +$216K 0.05% 226
2021
Q3 		– Sell
-4,160
Closed -$207K – 236
2021
Q2 		$207K Buy
+4,160
New +$200K 0.05% 222
2020
Q1 		– Sell
-4,160
Closed -$244K – 210
2019
Q4 		$244K Hold
4,160
– – 0.05% 210
2019
Q3 		$222K Hold
4,160
– – 0.07% 202
2019
Q2 		$208K Buy
+4,160
New +$209K 0.06% 247

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

MidWestOne Financial Group's GSK Position: Q2 2022 in Review

MidWestOne Financial Group sold out of GSK (GSK) in Q2 2022, closing a stake of 4,160 shares — an estimated $227K sold.

MidWestOne Financial Group first reported a position in GSK in Q2 2019 and held it in 6 quarters. The position peaked at $244K in Q4 2019. 900 funds tracked by Wall St. Rank hold GSK as of Q2 2022.

  • MidWestOne Financial Group reported no remaining GSK position as of Q2 2022 after selling out during the quarter.
  • MidWestOne Financial Group sold 4,160 GSK shares in Q2 2022, an estimated $227K.
  • MidWestOne Financial Group first reported a position in GSK in Q2 2019 and held it in 6 quarters.
  • MidWestOne Financial Group's GSK position peaked at $244K in Q4 2019.
  • 900 funds tracked by Wall St. Rank held GSK as of Q2 2022.

Based on MidWestOne Financial Group's 13F filing for Q2 2022, filed 16 Aug 2022.